Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jan 22, 2018 (9 years ago)

Ultane (sevoflurane)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51

Affected NDC 0074-4456-51

Compare with the code on your package — it is the most precise check available.

Drug: Sevoflurane

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Ultane
Sevoflurane
NDC 00074-4456
250 mL/250mL Liquid
Respiratory (inhalation)
AbbVie Inc. Rx
Recalling firm
AbbVie Inc.
NDC code
0074-4456-51
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0412-2018 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Sevoflurane recalls

See all
Class II · Moderate risk

Sevoflurane

Failed Stability Specifications

Terminated Stability / shelf life Baxter Healthcare Corporation NDC 10019-651-64 D-1435-2019
Class II · Moderate risk

Sevoflurane

Failed pH Specifications: product was too acidic.

Terminated Failed specification Piramal Critical Care, Inc. D-1262-2014

Other recalls by AbbVie Inc.

All 2018 recalls
Class II · Moderate risk

Refresh P.M.

Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

Ongoing Sterility / contamination AbbVie Inc. D-0664-2024
Class III · Low risk

Synthroid

Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.

Ongoing Labeling / mix-up AbbVie Inc. NDC 0074-7068-11 D-0088-2024